83
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Ivalin Inhibits Proliferation, Migration and Invasion by Suppressing Epithelial Mesenchymal Transition in Breast Cancer Cells

, , , , , , & show all
Pages 1330-1338 | Received 12 Apr 2018, Accepted 02 Oct 2018, Published online: 21 Nov 2018

References

  • DeSantis CE, Ma J, Goding Sauer A, Newman LA, and Jemal A: Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67, 439–448, 2017.
  • Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12, 895–904, 2006.
  • Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442–454, 2002.
  • Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362–374, 2003.
  • Coussens LM and Werb Z: Inflammation and cancer. Nature 420, 860–867, 2002
  • Condeelis J and Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266, 2006.
  • Thiery JP, Acloque H, Huang RY, and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139, 871–890, 2009.
  • Lee JM, Dedhar S, Kalluri R, and Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172, 973–981, 2006.
  • Peinado H, Olmeda D, and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer 7, 415–428, 2007.
  • Park SM, Gaur AB, Lengyel E, and Peter ME: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894–907, 2008.
  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al.: The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2, 76–83, 2000.
  • Sahlgren C, Gustafsson MV, Jin S, Poellinger L, and Lendahl U: Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 105, 6392–6397, 2008.
  • Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, et al.: The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26, 6979–6988, 2007.
  • Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715, 2008.
  • Xie Q, Mittal S, and Berens ME: Targeting adaptive glioblastoma: an overview of proliferation and invasion. Neuro-Oncol 16, 1575–1584, 2014.
  • Xie WD, Wang XR, Ma LS, Li X, and Row KH: Sesquiterpenoids from Carpesium divaricatum and their cytotoxic activity. Fitoterapia 83, 1351–1355, 2012.
  • Lee J, Min B, Lee S, Na M, Kwon B, et al.: Cytotoxic sesquiterpene lactones from Carpesium abrotanoides. Planta Med 68, 745–747, 2002.
  • Zhang JP, Xu XK, Ye J, Yang YX, Gao S, et al.: Three new sesquiterpene lactone dimers from Carpesium macrocephalum. Fitoterapia 110, 72–76, 2016.
  • Herz W and Hogenauer G: Ivalin, a new sesquiterpene lactone. J Org Chem 27, 905, 1962.
  • Herz W and Rajappa S: Stereochemistry of an ivalin degradation product. J Org Chem 28, 227, 1963.
  • Kim MR, Lee SK, Kim CS, Kim KS, and Moon DC: Phytochemical constituents of Carpesium macrocephalum F(R). et S(AV) ]. Arch Pharm Res 27, 1029–1033, 2004.
  • Harbeck N and Gnant M: Breast cancer. Lancet 389, 1134–1150, 2017.
  • Singh A and Settleman J: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741–4751, 2010.
  • Lamouille S, Xu J, and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15, 178–196, 2014.
  • Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, et al.: The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68, 537–544, 2008.
  • Hazan RB, Phillips GR, Qiao RF, Norton L, and Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis (vol 148, pg 779, 2000). J Cell Biol 148, 779–839, 2000.
  • Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, et al.: N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10, 4125–4133, 2004.
  • Zhang WT, Alt HA, Margulis A, Shamis Y, Fusenig NE, et al.: E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion. J Cell Sci 119, 283–291, 2006.
  • Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9, 265–273, 2009.
  • Liu YH: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15, 1–12, 2004.
  • Zeisberg M and Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429–1437, 2009.
  • Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112, 1776–1784, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.